
29.88 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 13.84 Today|||52-Week Range 62.49 | +1.15% Year-to-Date |
3 Big Reasons to Sell Cassava Sciences Stock Right Now Feb 01 / MotleyFool.com - Paid Partner Content |
Previous close | 29.59 |
Today’s open | 29.51 |
Day’s range | 28.53 - 30.18 |
Volume | 18,948 |
Average volume (3 months) | 1,550,407 |
Market cap | $1.3B |
Earnings growth (last year) | -238.75% |
Earnings growth (this year) | -142.28% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 4.87 |
Today’s change | Today’s % change | |
---|---|---|
GERNGeron Corp | -0.04 | -1.08% |
DCPHDeciphera Pharmaceut... | -0.13 | -0.78% |
AUPHAurinia Pharmaceutic... | -0.13 | -1.43% |
IOVAIovance Biotherapeut... | 0.00 | 0.00% |
Next reporting date | March 29, 2023 |
EPS forecast (this quarter) | -$0.56 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$32.4M |
Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Austin, Texas |